InvestSMART

Pharmaxis Ltd (ASX: PXS) - Announcements

- Current share price for PXS : $0.027

ASX company news and announcements for Pharmaxis Ltd (PXS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pharmaxis Ltd (PXS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pharmaxis Ltd (PXS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pharmaxis Ltd (PXS)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
- Successfully Completes Patient Enrolment-Bronchitol Phase II 16 Jul 2004 9:50AM $0.500 $0.027 fallen by 94.60%
- Successful application Pharmaceuticals Ptnrships Program 22 Apr 2004 9:45AM $0.500 $0.027 fallen by 94.60%
- Successful application Pharmaceuticals Ptnrships Program 22 Apr 2004 9:45AM $0.500 $0.027 fallen by 94.60%
- New Market Opportunity for Aridol 21 Apr 2004 10:11AM $0.510 $0.027 fallen by 94.71%
- New Market Opportunity for Aridol 21 Apr 2004 10:11AM $0.510 $0.027 fallen by 94.71%
- Disclosure Document 17 Mar 2004 4:24PM $0.540 $0.027 fallen by 95%
- Completes interim analysis on bronchitol study 23 Feb 2004 3:23PM $0.490 $0.027 fallen by 94.49%
- Half Yearly Report 6 Feb 2004 8:54AM $0.420 $0.027 fallen by 93.57%
- Pre-Quotation Disclosure 7 Nov 2003 1:52PM n/a $0.027 n/a
- Admission to Official List 7 Nov 2003 1:51PM n/a $0.027 n/a
- Admission to Official List 7 Nov 2003 1:51PM n/a $0.027 n/a

826 - 836 of 836 results

Page 34 of 34

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.